Category Archives: Open access

Talking drug prices #6: Openness vs. secrecy in drug development

Plos Blogs. October 22, 2015. By Mat Todd Contributors in this series on drug prices and access to medicines have mentioned important issues related to policy, finance and intellectual property. I’d like to make a few comments from the point of view … Continue reading

Posted in Delinkage, Innovation, Open access, Pricing | Leave a comment